Health Canada drug identification number

DIN 01989987 — MAGNEVIST 469 MG

MAGNEVIST is a solution of Gadopentetate dimeglumine marketed by BAYER INC. The full Gadopentetate dimeglumine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
01989987
Brand name
MAGNEVIST
Active ingredient
Gadopentetate dimeglumine
Strength
469 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
BAYER INC
Health Canada status
MARKETED
Drug class
Gadolinium-based contrast agent (linear ionic GBCA)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.